Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria del Hospital Universitario La Paz (21)

2024

  1. Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis

    Journal of Infection and Public Health, Vol. 17, Núm. 10

  2. Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era

    Journal of Biomedical Science, Vol. 31, Núm. 1

  3. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  4. Plasma metabolomic profile is near-normal in people with HIV on long-term suppressive antiretroviral therapy

    Frontiers in Cellular and Infection Microbiology, Vol. 14

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Corrigendum to “PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study” [Biomed. Pharmacother. 159 (2023) 114220] (Biomedicine & Pharmacotherapy (2023) 159, (S0753332223000082), (10.1016/j.biopha.2023.114220))

    Biomedicine and Pharmacotherapy

  3. Dynamics of cellular senescence markers after HCV elimination spontaneously or by DAAs in people living with HIV

    Biomedicine and Pharmacotherapy, Vol. 162

  4. HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART

    Journal of Medical Virology, Vol. 95, Núm. 7

  5. PBMCs gene expression signature of advanced cirrhosis with high risk for clinically significant portal hypertension in HIV/HCV coinfected patients: A cross-control study

    Biomedicine and Pharmacotherapy, Vol. 159

  6. Predictive plasma biomarkers of long-term increase in hepatic steatosis index after HCV eradication in HIV/HCV-coinfected patients

    Biomedicine and Pharmacotherapy, Vol. 164

2022

  1. Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 3, pp. 719-726

  2. HCV eradication with DAAs differently affects HIV males and females: A whole miRNA sequencing characterization

    Biomedicine and Pharmacotherapy, Vol. 145

  3. Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients

    Biomedicine and Pharmacotherapy, Vol. 147

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19

    Journal of Infection

2021

  1. Age-Adjusted Endothelial Activation and Stress Index for Coronavirus Disease 2019 at Admission Is a Reliable Predictor for 28-Day Mortality in Hospitalized Patients With Coronavirus Disease 2019

    Frontiers in Medicine, Vol. 8

  2. Different HCV exposure drives specific miRNA profile in PBMCS of HIV patients

    Biomedicines, Vol. 9, Núm. 11

  3. HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients

    Frontiers in Immunology, Vol. 12

  4. HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

    Journal of Biomedical Science, Vol. 28, Núm. 1

2020

  1. Comparison of methods and characterization of small RNAs from plasma extracellular vesicles of HIV/HCV coinfected patients

    Scientific Reports, Vol. 10, Núm. 1